GLP-1R, a novel receptor in platelets, and the use of liraglutide in the treatment of obesity in women with PCOS
Studies investigating atherothrombotic risk in women with polycystic ovary syndrome (PCOS), in particular platelet function and carotid intima-media wall thickness (cIMT), have been confounded by not adequately accounting for obesity. Liraglutide is a glucagon like peptide-1 (GLP-1) analogue that ca...
Saved in:
Main Author | |
---|---|
Format | Dissertation |
Language | English |
Published |
University of Hull and University of York
2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!